跳至主要内容
临床试验/CTRI/2013/10/004113
CTRI/2013/10/004113已完成4 期

Effect of Albendazole dose and interval on Wuchereria bancrofti microfilarial clearance in India: a randomized, open level study

Regional Medical Research Centre Chandrasekharpur Bhubaneswar0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • - Age 18 years to 55 years
  • - Men and non-pregnant or non-breastfeeding women
  • - Microfilarial levels >50 mf /ml
  • - Willingness to spend 3 days in hospital
  • - Willingness to undergo night time blood draws every 6 months for 2 years
  • - Ability to understand and sign the informed consent
  • - Hb levels for inclusion >9 g/dl
  • - Normal Cr, ALT

排除标准

  • â??Non-volunteers
  • â??Age < 18 years or > 55 years
  • â??Pregnancy or breast-feeding
  • â??Hgb <= 9 g/dL
  • â??Cr > 1.2/100 ml
  • â??ALT > 30 U
  • â??Alcohol consumption of more than 2 beers or other alcohol-containing drink/day within a week of each drug administration
  • â??Serious medical illness
  • â??History of benzimidazole allergy
  • â??History of DEC allergy
  • â??Use of Albendazole or DEC within past 6 months
  • â??Unwillingness to comply with required study visits

研究者

发起方
Regional Medical Research Centre Chandrasekharpur Bhubaneswar

相似试验